HDL Therapeutics Secures $2,045,000 Series B Funding

  • Feed Type
  • Date
    12/31/2014
  • Company Name
    HDL Therapeutics
  • Mailing Address
    46701 Commerce Center Drive Plymouth, MI 48170 USA
  • Company Description
    The company is developing various biotechnologies.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,045,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy